The European Medicines Agency approved a vaccine for the deadly Ebola Virus Disease. The vaccine has already been administered to hundreds of thousands of people in the Democratic Republic of the Congo, saving countless lives during an ongoing epidemic there. From Nature:
The decision by the European Medicines Agency (EMA) to allow US pharmaceutical company Merck to market its vaccine means that the product can now be stockpiled and, potentially, distributed more widely, in particular in Africa. In 2015, Gavi, the Vaccine Alliance — a global health partnership that funds vaccine supplies in low-income countries — told Ebola-vaccine manufacturers that it would commit to purchasing vaccines once they had been approved by a “stringent health authority” such as the EMA…
“This is a vaccine with huge potential,” said Seth Berkley, chief executive of Gavi in Geneva, Switzerland, in a press release after the EMA decision. “It has already been used to protect more than 250,000 people in the DRC and could well make major Ebola outbreaks a thing of the past.”
Image: “Ebola virus virion” by CDC/Cynthia Goldsmith (Public Domain)
